Allogene Therapeutics, Inc. (ALLO) vs Fate Therapeutics, Inc. (FATE)
Detailed comparison between Allogene Therapeutics, Inc., Fate Therapeutics, Inc..Total Return (%)
Allogene Therapeutics, Inc. (ALLO)Fate Therapeutics, Inc. (FATE)
Which stock do you think will perform better?
Allogene Therapeutics, Inc.
ALLO
Fate Therapeutics, Inc.
FATE
| Metric | Allogene Therapeutics, Inc. (ALLO) | Fate Therapeutics, Inc. (FATE) |
|---|---|---|
| Current Price | $1.24 | $1.00 |
| Change | -0.02 (-1.59%) | -0.05 (-4.76%) |
| Market Cap | $0.28B | $0.12B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -0.89 | -0.60 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $3.78 | $3.43 |
| 52-Week Low | $0.86 | $0.66 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-0.98 | $-1.33 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| ALLO | 2.48% | -35.42% | -43.89% | -95.95% | -95.04% | -95.04% |
| FATE | -32.89% | -25.37% | -56.33% | -98.16% | -75.73% | -75.73% |